Nogra Pharma

Clinical stage Company with a New Chemical Entity (NCE) in Phase2b/3 for Acne and completed Phase1b for Psoriasis, and NCEs directed against different targets in Lead Identification phase.

Highly focused on Dermatological Diseases, with Internal expertise, that enables NograPharma to develop Investigational Medicinal Products from target identification up to Marketing Authorization.

The Company Model is based on Interaction with Academies, Key Opinion Leaders and qualified Consultants for target identification, design of NCEs, nonclinical and Clinical Studies.